The relative dose intensity of first-line FOLFOXIRI and FOLFOX/FOLFIRI both in combination with bevacizumab affects prognosis of metastatic colorectal cancer patients: A pooled analysis of TRIBE and TRIBE2 studies. - Moretto R; Rossini D; Polito MG; Antoniotti C; Intini R; Conca V; Andena P; Carullo M; Salvatore L; Germani MM; Bergamo F; Passardi A; et al. (European journal of cancer (Oxford, England : 1990), 2025)